148 related articles for article (PubMed ID: 37215860)
1. HAART induced inflammation, toxicity and its determinants among HIV positive children in Addis Ababa, Ethiopia.
Getaneh Y; Lejissa T; Getahun T; Khairunisa SQ; Husada D; Kuntaman K; Lusida MI
Heliyon; 2023 May; 9(5):e15779. PubMed ID: 37215860
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia.
Ayele G; Tessema B; Amsalu A; Ferede G; Yismaw G
BMC Immunol; 2018 Dec; 19(1):37. PubMed ID: 30558580
[TBL] [Abstract][Full Text] [Related]
3. Clinical, Immunological and Virological Responses of Zidovudine-Lamivudine-Nevirapine
Sorsa A
Open Med Inform J; 2018; 12():11-18. PubMed ID: 29875890
[TBL] [Abstract][Full Text] [Related]
4. Intestinal parasitosis in relation to CD4+T cells levels and anemia among HAART initiated and HAART naive pediatric HIV patients in a Model ART center in Addis Ababa, Ethiopia.
Mengist HM; Taye B; Tsegaye A
PLoS One; 2015; 10(2):e0117715. PubMed ID: 25658626
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital, Ethiopia.
Assefa M; Abegaz WE; Shewamare A; Medhin G; Belay M
BMC Hematol; 2015; 15():6. PubMed ID: 26045966
[TBL] [Abstract][Full Text] [Related]
6. Effects of Highly Active Antiretroviral Therapy on Renal Function and Renal Phosphate Handling in African Adults with Advanced HIV and CKD.
Adedeji TA; Adebisi SA; Adedeji NO; Biliaminu SA; Olanrewaju TO
Infect Disord Drug Targets; 2019; 19(1):88-100. PubMed ID: 30027856
[TBL] [Abstract][Full Text] [Related]
7. Immunological outcomes of Tenofovir versus Zidovudine-based regimens among people living with HIV/AIDS: a two years retrospective cohort study.
Ayele T; Jarso H; Mamo G
AIDS Res Ther; 2017 Feb; 14(1):5. PubMed ID: 28143541
[TBL] [Abstract][Full Text] [Related]
8. Efavirenz and ritonavir-boosted lopinavir use exhibited elevated markers of atherosclerosis across age groups in people living with HIV in Ethiopia.
Gleason RL; Caulk AW; Seifu D; Rosebush JC; Shapiro AM; Schwartz MH; Eckard AR; Amogne W; Abebe W
J Biomech; 2016 Sep; 49(13):2584-2592. PubMed ID: 27270208
[TBL] [Abstract][Full Text] [Related]
9. Effects of Highly Active Antiretroviral Therapy on Albuminuria in HIVinfected Persons.
Adedeji TA; Adebisi SA; Adedeji NO
Infect Disord Drug Targets; 2020; 20(3):374-384. PubMed ID: 31389318
[TBL] [Abstract][Full Text] [Related]
10. Contraceptive use and method preference among HIV positive women in Addis Ababa, Ethiopia: a cross sectional survey.
Asfaw HM; Gashe FE
BMC Public Health; 2014 Jun; 14():566. PubMed ID: 24902478
[TBL] [Abstract][Full Text] [Related]
11. The magnitude of hypertension and associated factors among clients on highly active antiretroviral treatment in Southern Ethiopia, 2020: A hospital-based cross-sectional study.
Lukas K; Markos E; Belayneh F; Habte A
PLoS One; 2021; 16(10):e0258576. PubMed ID: 34653207
[TBL] [Abstract][Full Text] [Related]
12. Renal Function Impairment and Associated Factors among HAART Naïve and Experienced Adult HIV Positive Individuals in Southwest Ethiopia: A Comparative Cross Sectional Study.
Mekuria Y; Yilma D; Mekonnen Z; Kassa T; Gedefaw L
PLoS One; 2016; 11(8):e0161180. PubMed ID: 27537338
[TBL] [Abstract][Full Text] [Related]
13. WITHDRAWN. Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV.
Omeje I; Okwundu CI
Cochrane Database Syst Rev; 2012 Feb; (2):CD007276. PubMed ID: 22336829
[TBL] [Abstract][Full Text] [Related]
14. Beyond clinical trials: Cross-sectional associations of combination antiretroviral therapy with reports of multiple symptoms and non-adherence among adolescents in South Africa.
Natukunda HPM; Cluver LD; Toska E; Musiime V; Yakubovich AR
S Afr Med J; 2017 Oct; 107(11):965-975. PubMed ID: 29262938
[TBL] [Abstract][Full Text] [Related]
15. Predictors of adverse drug reaction among adult HIV-infected patients on antiretroviral therapy in government hospitals of Kaffa Zone, Ethiopia; November 2018: a retrospective cohort.
Mitkie AA; Bekele FB; Debiso AT
Pan Afr Med J; 2021; 38():181. PubMed ID: 33995787
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Immuno-virological status and its associated factors among HIV-positive patients receiving highly active antiretroviral therapy at delgi primary hospital, northwest Ethiopia, 2020/2021: A cross-sectional study.
Kiros T; Taye A; Workineh L; Eyayu T; Damtie S; Hailemichael W; Tiruneh T
Heliyon; 2022 Aug; 8(8):e10169. PubMed ID: 36033289
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Disease Progression and Drug Resistance Mutations among Children on First-Line Antiretroviral Therapy in Ethiopia.
Getaneh Y; Getnet F; Ning F; Rashid A; Liao L; Yi F; Shao Y
Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626789
[No Abstract] [Full Text] [Related]
19. Central Obesity and Associated Factors among Adult Patients on Antiretroviral Therapy (ART) in Armed Force Comprehensive and Specialized Hospital, Addis Ababa, Ethiopia.
Kemal A; Ahmed M; Sinaga Teshome M; Abate KH
J Obes; 2021; 2021():1578653. PubMed ID: 34504719
[TBL] [Abstract][Full Text] [Related]
20. Causes for antiretroviral regimen change among HIV/AIDS patients in Addis Ababa, Ethiopia.
Jima YT; Angamo MT; Wabe NT
Tanzan J Health Res; 2013 Jan; 15(1):11-8. PubMed ID: 26591668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
